Digital Pathology Market Beyond the Microscope: The Rise of Digital Pathology and its Impact on Diagnostics

Digital Pathology Market

Digital Pathology Market to reach over USD 2731.95 million by the year 2031 - Exclusive Report by InsightAce Analytic

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Pathology Market Size, Share & Trends Analysis Report By Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals)- Market Outlook And Industry Analysis 2031"

The global digital pathology market is estimated to reach over USD 2731.95 million by 2024-2031, exhibiting a CAGR of 12.91% during the forecast period.

Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1629

Factors Driving Growth in the Digital Pathology Market
Several factors are fueling the expansion of the digital pathology market. The increasing incidence of cancer creates a larger demand for advanced diagnostic tools, propelling the use of digital pathology. Digital pathology is also finding growing use in internet-based and pharmaceutical research, further driving market growth.

Many laboratories are adopting digital pathology to streamline workflows and improve overall lab efficiency. The increasing prevalence of cardiovascular diseases is a significant driver for the development of innovative diagnostic methods, including digital pathology. As a result, the demand for digital pathology systems is expected to rise throughout the forecast period. Technological advancements like computerization, robotic light microscopy, and various fiber optic links are contributing to the wider adoption of digital pathology.

Other Positive Developments
The emergence of cost-effective scanners allows smaller pathology labs to consider digitizing their processes, further expanding the market. The introduction of cloud-based technology offers secure storage for digital slides, accessible to authorized pathologists. This is expected to facilitate the future growth of the digital pathology market.

Challenges to Market Growth
Despite these positive trends, some challenges remain. The high cost of digital pathology systems can be a significant barrier for some labs. Finding qualified personnel to operate and manage digital pathology equipment can also be challenging.

List of Prominent Players in the Digital Pathology Market:
• PathAI (US)
• Proscia Inc. (US)
• Kanteron Systems (Spain)
• Mikroscan Technologies (US)
• Motic (US)
• Paige (US)
• Biosystems (US)
• Koninklijke Philips N.V. (Netherlands)
• Hamamatsu Photonics (Japan)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• 3DHISTECH (Hungary)
• Apollo Enterprise Imaging (US)
• XIFIN, Inc. (US)
• Huron Digital Pathology (Canada)
• Visiopharm A/S (Denmark)
• Aiforia Technologies Oy (Finland)
• Akoya Biosciences (US)
• Corista (US)
• Indica Labs (US)
• Objective Pathology Services (Canada)
• Sectra AB (Sweden)
• OptraSCAN (US)
• Glencoe Software (US)
• KONFOONG BIOTECH INTERNATIONAL CO., LTD. (China)
• Inspirata, Inc. (US)

Market Dynamics:
Drivers-
The success of digital pathology in research is driving the demand for these systems from the cancer research sector. This also attracts government investors to invest in digital pathology systems for clinical diagnostics applications. Technological advancements such as computerization, robotic light microscopy, and multiple fiber optic communications are important key factors projected to increase the adoption of {{keyword}} in the future.

Great-throughput technologies for drug discovery are also in high demand, which could help the device catch on. The adoption of pathological digitization may also increase demand for the services. These elements could fuel market expansion for digital pathology.

Challenges:
Inhibitors to market expansion over the forecast period include strict regulatory concerns for primary diagnosis and a lack of uniform norms for digital pathology. Inhibitors to market expansion over the forecast period include strict regulatory concerns for primary diagnosis and a lack of uniform norms for digital pathology. The deployment of these devices is anticipated to be constrained by their high cost and the difficulty of finding qualified individuals to operate digital pathology devices.

Regional Trends:
North America has a mature market for digital pathology products in the field of marketing during the forecast period. The growing prevalence of cancer, the expanding use of digital pathology in pharmaceutical research and online as part, and the ever-increasing acceptance of digital pathology to improve lab efficiency are the primary drivers of the market's growth. Besides, Europe had a substantial share of the digital pathology market. The need for digital pathology increased as customers' preferences for digital tools increased. Additionally, expanding the use of products with advanced technology is likely to support market expansion.

Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/1629

Recent Developments:
• In March 2022-Ion Torrent Genexus Dx Integrated Sequencer, an automated next-generation sequencing (NGS) platform for use in clinical laboratories and to conduct diagnostic and clinical research, was introduced by Thermo Fisher Scientific, Inc. with the CE-IVD marking.

• In April 2022-A contract between the Catalan Health Institute and 3DHISTECH Ltd. was signed. This plan was implemented to introduce digital pathology tools across an eight-hospital network.

Segmentation of Digital Pathology Market-

By Product
• Scanners
o Brightfield
o Other Scanners
• Software
o Integrated Software
o Standalone Software
 Information Management Software
 Image Analysis Software
• Storage Systems

By Type
• Human Pathology
• Veterinary Pathology
By Application
• Drug Discovery
• Disease Diagnosis
• Training & Education
By End User
• Pharmaceutical & Biotechnology Companies
• Hospitals and Reference Laboratories
• Academic & Research Institutes
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

For More Customization @ https://www.insightaceanalytic.com/report/digital-pathology-market/1629

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.